Acta Med. 2010, 53: 213-220
https://doi.org/10.14712/18059694.2016.79
How I Treat Elderly or Comorbid Patients with Chronic Lymphocytic Leukemia
Crossref Cited-by Linking
- Steingrímsson Vilhjálmur, Lund Sigrún H., Dickman Paul W., Weibull Caroline E., Björkholm Magnus, Landgren Ola, Kristinsson Sigurður Y.: Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre‐ibrutinib era: A population‐based study. European J of Haematology 2022, 108, 145. <https://doi.org/10.1111/ejh.13720>
- Montillo Marco, Illés Árpád, Robak Tadeusz, Pristupa Alexander S., Wach Malgorzata, Egyed Miklós, Delgado Julio, Jurczak Wojciech, Morschhauser Franck, Schuh Anna, Eradat Herbert, Shreay Sanatan, Barrientos Jacqueline C., Zelenetz Andrew D.: Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial. Health Qual Life Outcomes 2019, 17. <https://doi.org/10.1186/s12955-019-1232-8>
- Strugov Vladimir, Stadnik Elena, Virts Yulia, Andreeva Tatyana, Zaritskey Andrey: Impact of age and comorbidities on the efficacy of FC and FCR regimens in chronic lymphocytic leukemia. Ann Hematol 2018, 97, 2153. <https://doi.org/10.1007/s00277-018-3409-3>
- Satram-Hoang Sacha, Reyes Carolina, Hoang Khang Q., Momin Faiyaz, Skettino Sandra: The Unmet Need in Chronic Lymphocytic Leukemia: Impact of Comorbidity Burden on Treatment Patterns and Outcomes in Elderly Patients. JCT 2013, 04, 1321. <https://doi.org/10.4236/jct.2013.48156>
- Yonal Ipek, Nazl\u0131gul Esra, Tas Gulsum, Agan Mehmet Ramazan, Yenerel Mustafa Nuri, Nalcaci Meliha: A case of chronic lymphocytic leukemia with massive ascites. Rare Tumors 2012, 4, 165. <https://doi.org/10.4081/rt.2012.e51>
